| Literature DB >> 29457038 |
Jinkyung Cho1, Haeryun Hong1, Soohyun Park2, Shinuk Kim3, Hyunsik Kang1.
Abstract
BACKGROUND: This study investigated the association between insulin resistance (IR) and metabolic syndrome (MetS) in children.Entities:
Mesh:
Substances:
Year: 2017 PMID: 29457038 PMCID: PMC5804402 DOI: 10.1155/2017/8728017
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Description of anthropometrics and metabolic risk factors in study participants.
| Variables | Total ( | Boys ( | Girls ( |
|
|---|---|---|---|---|
|
| ||||
| Age (years) | 10.5 ± 1.7 | 10.1 ± 1.7 | 10.8 ± 1.7 | 0.198 |
| BMI (kg/m2) | 19.1 ± 3.4 | 19.1 ± 3.3 | 19.3 ± 3.4 | 0.409 |
| Body fat (%) | 11.1 ± 7.8 | 10.3 ± 6.4 | 11.7 ± 8.8 | 0.007 |
| WC (cm) | 67.7 ± 11.3 | 67.1 ± 11.3 | 68.3 ± 11.2 | 0.091 |
|
| ||||
| SBP (mmHg) | 107.1 ± 14.5 | 107.3 ± 15.3 | 106.9 ± 13.8 | 0.683 |
| DBP (mmHg) | 65.2 ± 10.5 | 64.8 ± 10.5 | 65.5 ± 10.4 | 0.288 |
|
| ||||
| TG (mg/dL) | 88.4 ± 47.9 | 86.8 ± 48.1 | 89.7 ± 47.7 | 0.336 |
| TC (mg/dL) | 174.0 ± 32.3 | 173.7 ± 32.7 | 174.1 ± 32.0 | 0.841 |
| HDL-C (mg/dL) | 56.0 ± 13.4 | 56.3 ± 13.5 | 55.7 ± 13.2 | 0.476 |
| Glucose (mg/dL) | 91.1 ± 9.7 | 90.3 ± 8.7 | 91.9 ± 10.5 | 0.005 |
| Insulin ( | 9.1 ± 6.0 | 9.0 ± 5.7 | 9.2 ± 6.2 | 0.530 |
| HOMA-IR | 2.1 ± 1.4 | 2.0 ± 1.4 | 2.1 ± 1.5 | 0.336 |
|
| ||||
| 0 | 48.4 | 55.7 | 41.8 | 0.055 |
| 1 | 31.7 | 29.3 | 33.8 | 0.020 |
| 2 | 14.3 | 10.5 | 17.7 | <0.001 |
| ≥3 components | 5.7 | 4.5 | 6.8 | 0.051 |
BMI: body mass index; WC: waist circumference; SBP: systolic blood pressure; DBP: diastolic blood pressure; TG: triglycerides; TC: total cholesterol; HDL-C: high density lipoprotein-cholesterol.
Anthropometrics and metabolic risk factors according to HOMA-IR quartiles.
| Variables | HOMA-IR quartiles | ||||
|---|---|---|---|---|---|
| Q1 | Q2 | Q3 | Q4 |
| |
| (<1.13) | (1.13–1.65) | (1.65–2.65) | (>2.65) | trend | |
|
| 10.3 ± 1.9 | 10.3 ± 1.8 | 10.8 ± 1.6 | 11.4 ± 1.3 | <0.001 |
|
| |||||
| BMI (kg/m2) | 17.3 ± 2.6 | 18.4 ± 2.8 | 19.6 ± 3.2 | 21.4 ± 3.6 | <0.001 |
| Body fat (%) | 7.9 ± 6.5 | 8.6 ± 6.4 | 10.1 ± 6.4 | 16.5 ± 8.2 | <0.001 |
| WC (cm) | 62.5 ± 10.2 | 64.9 ± 10.3 | 69.2 ± 10.6 | 74.5 ± 10.1 | <0.001 |
|
| |||||
| SBP (mmHg) | 104.2 ± 14.8 | 106.1 ± 13.0 | 107.4 ± 13.7 | 110.8 ± 15.2 | <0.001 |
| DBP (mmHg) | 63.8 ± 11.0 | 64.1 ± 8.8 | 65.1 ± 8.9 | 66.7 ± 11.8 | <0.001 |
|
| |||||
| TG (mg/dL) | 70.0 ± 29.9 | 77.9 ± 41.1 | 95.5 ± 50.1 | 110.8 ± 55.2 | <0.001 |
| TC (mg/dL) | 169.3 ± 29.5 | 171.3 ± 29.5 | 173.3 ± 27.8 | 182.7 ± 39.1 | <0.001 |
| HDL-C (mg/dL) | 61.3 ± 13.5 | 58.7 ± 12.6 | 53.8 ± 12.8 | 50.3 ± 11.9 | <0.001 |
| Glucose (mg/dL) | 86.2 ± 8.2 | 90.9 ± 8.6 | 91.6 ± 8.1 | 95.5 ± 10.7 | <0.001 |
| Insulin ( | 3.8 ± 1.1 | 6.2 ± 0.9 | 9.3 ± 1.5 | 17.0 ± 6.3 | <0.001 |
BMI: body mass index; WC: waist circumference; SBP: systolic blood pressure; DBP: diastolic blood pressure; TG: triglycerides; TC: total cholesterol; HDL-C: high density lipoprotein-cholesterol; FBG: fasting blood glucose. p values were adjusted for age and sex using general linear models.
Odds ratio (OR) and 95 confidence interval (95% CI) of metabolic abnormalities according to HOMA-IR quartiles.
| Metabolic abnormalities | HOMA-IR quartiles (values | |||
|---|---|---|---|---|
| Q1 | Q2 | Q3 | Q4 | |
| (<1.13) | (1.13–1.65) | (1.65–2.65) | (>2.65) | |
|
| ||||
| Unadjusted OR | Referent | 1.48 | 3.89 | 8.40 |
| 95% CI | - | 0.78–2.78 | 2.22–6.80 | 4.89–14.42 |
| | - | 0.225 | <0.001 | <0.001 |
| Adjusted OR | Referent | 0.58 | 1.10 | 1.68 |
| 95% CI | - | 0.37–0.89 | 0.73–1.63 | 1.12–2.50 |
| | - | 0.189 | 0.813 | 0.182 |
|
| ||||
| Unadjusted OR | Referent | 1.36 | 1.70 | 2.41 |
| 95% CI | - | 0.75–2.43 | 0.96–2.97 | 1.40–4.12 |
| | - | 0.303 | 0.065 | 0.001 |
| Adjusted OR | Referent | 1.14 | 1.34 | 1.90 |
| 95% CI | - | 0.83–1.57 | 0.97–1.85 | 1.35–2.66 |
| | - | 0.662 | 0.344 | 0.051 |
|
| ||||
| Unadjusted OR | Referent | 1.00 | 1.33 | 1.99 |
| 95% CI | - | 0.63–1.57 | 0.86–2.04 | 1.31–3.01 |
| | - | 1.000 | 0.198 | 0.001 |
| Adjusted OR | Referent | 0.91 | 1.25 | 2.03 |
| 95% CI | - | 0.71–1.16 | 0.97–1.59 | 1.56–2.63 |
| | - | 0.687 | 0.349 | 0.005 |
|
| ||||
| Unadjusted OR | Referent | 4.15 | 5.63 | 15.62 |
| 95% CI | - | 1.76–9.73 | 2.45–12. 92 | 7.04–34.63 |
| | - | 0.001 | <0.001 | <0.001 |
| Adjusted OR | Referent | 4.97 | 6.70 | 19.54 |
| 95% CI | - | 3.07–8.03 | 4.32–11.1 | 12.1–31.3 |
| | - | 0.001 | <0.001 | <0.001 |
|
| ||||
| Unadjusted OR | Referent | 2.50 | 7.43 | 15.11 |
| 95% CI | - | 0.88–7.33 | 2.85–19.34 | 5.95–38.35 |
| | - | 0.083 | <0.001 | <0.001 |
| Adjusted OR | Referent | 1.81 | 4.56 | 7.64 |
| 95% CI | - | 1.06–3.06 | 2.82–7.34 | 4.73–12.34 |
| | - | 0.246 | 0.001 | <0.001 |
|
| ||||
| Unadjusted OR | Referent | 0.94 | 1.13 | 2.34 |
| 95% CI | - | 0.58–1.54 | 0.70–1.80 | 1.45–3.45 |
| | - | 0.817 | 0.618 | <0.001 |
| Adjusted OR | Referent | 0.92 | 1.06 | 1.83 |
| 95% CI | - | 0.70–1.20 | 0.81–1.37 | 1.41–2.38 |
| | - | 0.748 | 0.820 | 0.016 |
|
| ||||
| Unadjusted OR | Referent | 1.09 | 3.33 | 5.39 |
| 95% CI | - | 0.71–1.67 | 2.333–4.77 | 3.81–7.61 |
| | - | 0.830 | <0.001 | <0.001 |
| Adjusted OR | Referent | 1.00 | 2.52 | 2.70 |
| 95% CI | - | 0.64–1.54 | 1.74–3.64 | 1.86–3.91 |
| | - | 0.999 | 0.010 | 0.006 |
WC: waist circumference; SBP: systolic blood pressure; DBP: diastolic blood pressure; TG: triglycerides; HDL-C: high density lipoprotein-cholesterol. Adjusted for age and sex. Adjusted OR for age, sex, BMI, and body fat percentage.
Odds ratio (OR) and 95% confidence interval (95% CI) of the 4th HOMA-IR quartile for having metabolic syndrome.
| HOMA-IR quartile (value | OR | 95% CI |
|
|---|---|---|---|
| Referent (HOMA-IR of ≥2.65) | 1 | - | - |
| Unadjusted OR | 6.65 | 3.89–11.38 | <0.001 |
| Adjusted OR | 3.79 | 1.96–7.32 | <0.001 |
HOMA-IR: homeostasis model assessment of insulin resistance. Adjusted for age and sex. Adjusted OR for age, sex, BMI, body fat percentage, waist circumference, and WHR.
Figure 1Receiver operating curve analysis of HOMA-IR values for metabolic syndrome in the study population.